Open AccessPostprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor–based or nonnucleoside reverse transcriptase inhibitor–based antiretroviral therapy
Author(s) -
Asha Thomas-Geevarghese,
Subhashree Raghavan,
Robert Minolfo,
Steve Holleran,
Rajasekhar Ramakrishnan,
Bernard Ormsby,
Wahida Karmally,
Henry N. Ginsberg,
Wafaa ElSadr,
Jeanine Albu,
Lars Berglund
Publication year - 2005
Publication title -
american journal of clinical nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.608
H-Index - 336
eISSN - 1938-3207
pISSN - 0002-9165
DOI - 10.1093/ajcn.82.1.146
Subject(s) - medicine , reverse transcriptase inhibitor , nevirapine , regimen , postprandial , indinavir , efavirenz , nelfinavir , lipodystrophy , interquartile range , gastroenterology , endocrinology , viral load , insulin , immunology , human immunodeficiency virus (hiv) , antiretroviral therapy
Features of the dyslipidemic pattern reported with the use of antiretroviral therapy predict enhanced postprandial lipemia, which is an emerging cardiovascular disease risk factor.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom